- Home
- FE vs ZBH Comparison
FE vs ZBH Comparison
Compare FE & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FE
- ZBH
- Stock Information
- Founded
- FE 1996
- ZBH 1927
- Country
- FE United States
- ZBH United States
- Employees
- FE N/A
- ZBH N/A
- Industry
- FE Electric Utilities: Central
- ZBH Industrial Specialties
- Sector
- FE Utilities
- ZBH Health Care
- Exchange
- FE Nasdaq
- ZBH Nasdaq
- Market Cap
- FE 23.9B
- ZBH 19.9B
- IPO Year
- FE N/A
- ZBH N/A
- Fundamental
- Price
- FE $46.16
- ZBH $101.16
- Analyst Decision
- FE Buy
- ZBH Buy
- Analyst Count
- FE 15
- ZBH 19
- Target Price
- FE $48.67
- ZBH $111.50
- AVG Volume (30 Days)
- FE 5.0M
- ZBH 1.3M
- Earning Date
- FE 10-22-2025
- ZBH 11-05-2025
- Dividend Yield
- FE 3.87%
- ZBH 0.96%
- EPS Growth
- FE 48.81
- ZBH N/A
- EPS
- FE 2.31
- ZBH 4.11
- Revenue
- FE $14,283,000,000.00
- ZBH $7,833,800,000.00
- Revenue This Year
- FE $9.16
- ZBH $8.18
- Revenue Next Year
- FE $3.64
- ZBH $5.91
- P/E Ratio
- FE $19.96
- ZBH $24.30
- Revenue Growth
- FE 7.74
- ZBH 4.11
- 52 Week Low
- FE $37.58
- ZBH $89.22
- 52 Week High
- FE $48.20
- ZBH $114.72
- Technical
- Relative Strength Index (RSI)
- FE 50.97
- ZBH 52.19
- Support Level
- FE $45.15
- ZBH $97.89
- Resistance Level
- FE $46.45
- ZBH $101.87
- Average True Range (ATR)
- FE 0.71
- ZBH 2.07
- MACD
- FE -0.22
- ZBH -0.08
- Stochastic Oscillator
- FE 33.06
- ZBH 36.41
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with 10 regulated distribution utilities across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.